175 related articles for article (PubMed ID: 35510556)
1. New-onset bullous pemphigoid and flare of pre-existing bullous pemphigoid after the third dose of the COVID-19 vaccine.
Bardazzi F; Carpanese MA; Abbenante D; Filippi F; Sacchelli L; Loi C
Dermatol Ther; 2022 Jul; 35(7):e15555. PubMed ID: 35510556
[No Abstract] [Full Text] [Related]
2. Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et al.
Martora F; Ruggiero A; Battista T; Fabbrocini G; Megna M
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e35-e36. PubMed ID: 35974447
[No Abstract] [Full Text] [Related]
3. Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.
Dell'Antonia M; Anedda S; Usai F; Atzori L; Ferreli C
Dermatol Ther; 2022 Jan; 35(1):e15208. PubMed ID: 34786801
[No Abstract] [Full Text] [Related]
4. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
5. Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center.
Afacan E; Edek YC; İlter N; Gülekon A
Int J Dermatol; 2022 May; 61(5):626-627. PubMed ID: 35080255
[No Abstract] [Full Text] [Related]
6. A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.
Daines B; Madigan LM; Vitale PA; Khalighi M; Innes M
Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259862
[TBL] [Abstract][Full Text] [Related]
7. Bullous pemphigoid after inactivated COVID-19 vaccination: Case report.
Zhang Y; Lang X; Guo S; He H; Cui H
Dermatol Ther; 2022 Aug; 35(8):e15595. PubMed ID: 35608483
[No Abstract] [Full Text] [Related]
8. Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab.
Baffa ME; Maglie R; Montefusco F; Pipitò C; Senatore S; Antiga E
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e135-e137. PubMed ID: 36268775
[No Abstract] [Full Text] [Related]
9. Reply to "New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin".
Maronese CA; Di Zenzo G; Genovese G; Barei F; Monestier A; Pira A; Moltrasio C; Marzano AV
Dermatol Ther; 2022 Jun; 35(6):e15496. PubMed ID: 35388592
[No Abstract] [Full Text] [Related]
10. Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen.
Chan LS; Dorman MA; Agha A; Suzuki T; Cooper KD; Hashimoto K
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):331-5. PubMed ID: 8436652
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid and COVID-19 vaccine.
Pérez-López I; Moyano-Bueno D; Ruiz-Villaverde R
Med Clin (Barc); 2021 Nov; 157(10):e333-e334. PubMed ID: 34119340
[No Abstract] [Full Text] [Related]
12. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
13. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.
Tomayko MM; Damsky W; Fathy R; McMahon DE; Turner N; Valentin MN; Rallis T; Aivaz O; Fox LP; Freeman EE
J Allergy Clin Immunol; 2021 Sep; 148(3):750-751. PubMed ID: 34275656
[No Abstract] [Full Text] [Related]
14. Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al.
Avallone G; Giordano S; Astrua C; Merli M; Senetta R; Conforti C; Ribero S; Marzano AV; Quaglino P
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e433-e435. PubMed ID: 35067994
[No Abstract] [Full Text] [Related]
15. Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.
Sun L; Brazão C; Mancha D; Soares-de-Almeida L; Filipe P
J Eur Acad Dermatol Venereol; 2023 May; 37(5):e578-e580. PubMed ID: 36681888
[No Abstract] [Full Text] [Related]
16. New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin.
Bostan E; Yel B; Akdogan N; Gokoz O
Dermatol Ther; 2022 Feb; 35(2):e15241. PubMed ID: 34854184
[No Abstract] [Full Text] [Related]
17. A case of anti-p200 pemphigoid after COVID-19 vaccination.
Shimamoto K; Someda Y; Ushimura A; Tateishi C; Hayashi D; Tsuruta D; Hashimoto T; Goto H
Eur J Dermatol; 2024 Apr; 34(2):220-221. PubMed ID: 38907563
[No Abstract] [Full Text] [Related]
18. Bullous Pemphigoid Developed after the COVID-19 Vaccine.
Linares-Navarro R; Ramírez GR; Perandones-González H; Rodríguez-Prieto MÁ
Skinmed; 2023; 21(3):200-202. PubMed ID: 37634107
[TBL] [Abstract][Full Text] [Related]
19. Peristomal bullous pemphigoid.
Marzano AV; Vezzoli P; Colombo A; Serini SM; Crosti C; Berti E
J Dermatol; 2010 Sep; 37(9):840-2. PubMed ID: 20883375
[No Abstract] [Full Text] [Related]
20. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
[No Abstract] [Full Text] [Related]
[Next] [New Search]
